Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., launches a new YouTube channel. The Eye on FDA YouTube channel will aggregate healthcare videos in various subject areas, with a concentration on oncology, diabetes and HIV, in one, easily-accessible place.
Washington, DC (PRWEB) August 27, 2008 — This week Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., launched a new YouTube channel to aggregate healthcare videos in various subject areas on a single site.
The Eye on FDA YouTube channel is accessible by going directly to YouTube or can be accessed at the Eye on FDA site in a sidebar containing direct links to the various playlists.
The Eye on FDA YouTube channel features playlists that are disease-specific in oncology, diabetes and HIV, with plans to expand to other disease and chronic conditions. The site also aggregates videos on public health, including various videos produced by the government, as well as FDA videos that are product-specific announcements. In addition, investors will be able to access an aggregation of videos on finance matters produced by Bloomberg, theStreet.com and other financial resources.
The Eye on FDA YouTube channel added to the Web site expands the Eye on FDA offering of daily blog postings and daily twitter updates to offer an integrated strategic approach to engage the growing sector of digital followers with healthcare and pharmaceutical interests.
Mark Senak’s Eye On FDA
‘Eye on FDA’ has a diverse ‘readership’, including national media, government officials, patient groups, law firms, stock analysts and pharmaceutical companies themselves.
